genomics
In a small validation set, the model was able to make accurate predictions about patient outcomes using routinely collected patient data.
4baseCare, Innovate Life Sciences Partner to Bring Cancer Genomics Testing Services to Dubai
The partners plan to offer genomic testing, such as cancer gene panels, whole-exome, and transcriptome analysis, to cancer patients in the Middle East.
Immuneering Takes Lead Agent Into Phase II Trial Betting on Universal RAS Inhibition in Solid Tumors
Premium
The firm is evaluating IMM-1-104 in the Phase IIa portion of a trial involving patients with pancreatic cancer and RAS-mutant melanoma and NSCLC.
African Cancer Genome Registry Seeks Participants to Improve Understanding of Higher Risk, Mortality
The study will recruit about 2,000 patients of African ancestry to identify genomic, socioeconomic, and lifestyle factors associated with cancer.
GeneCentric Begins Study to Validate RNA Gene Signature Test in Bladder Cancer
GeneCentric investigators will assess the ability of the FGFR predictive response signature to identify bladder cancer patients who may benefit from targeted therapy.
Apr 11, 2022